A Run With a Mission

More than 1,500 attendees rose early on a beautiful Sunday morning in Orlando to participate in the 2019 ASH Foundation Run/Walk. ASH is pleased to announce that this year’s sponsors, runners, walkers, and all of their supporters helped the Foun dation raise a total...

The Road to Wisdom: ASH-ASPHO Pediatric Choosing Wisely Collaboration

By Lynn Malec, MD, MSc, and Janice Staber, MD “We are made wise not by the recollection of our past, but by the responsibility for our future.”  – George Bernard Shaw The Choosing Wisely® campaign is an effort led by the American Board of Internal Medicine...
Cutting Costs for CML Abroad

Cutting Costs for CML Abroad

By Ilana Yurkiewicz, MD “If you have to get cancer,” I once reassured a frightened patient, “CML [chronic myeloid leukemia] isn’t bad.” CML is truly one of our cancer success stories. The identification of a single genetic swap — BCR-ABL — and the development of...

Constructing an Idea: From Wings to Landing Gear

By Janice Staber, MD “Great ideas need landing gear as well as wings.” — Charles Douglas Jackson In the Special-Interest Session, Systems-Based Hematology: How to Implement Evidence-Based Programs for Virtual Hematology Consults and Anticoagulation Stewardship, Michal...
Welcome to Orlando

Welcome to Orlando

Ayesha N. Zia, MD ASH News Daily Editor-in-Chief The Hebrew word for it is hrh. The Hindus speak of prabodhan. In Chinese, it’s qishi. The teachings of Buddhism discuss bodhi … keihatsu in Japanese. The French use eclaircissement. In my native language, Urdu, it...

Blood Welcomes New Editions to the International Roster

After the uniquely positive experiences following the launch of the initial local language editions of Blood in Italy, Spain, and Latin America, we are delighted to announce that two new editions are being added to the international family of journals: Chinese Blood...

Spotlight on Global Capacity Building

The Global Capacity-Building Showcase (Hall B, Level 2 [Orange County Convention Center] – map it ) is an annual meeting poster category designed to encourage international collaborations in the form of capacity-building programs in low- and middle-income...

ASH Research Collaborative Sickle Cell Disease Clinical Trials Network

The ASH Research Collaborative (ASH RC) was established by ASH in 2018 with the goal of fostering collaborative partnerships to accelerate progress in hematology and improve lives of those affected by blood diseases. The ASH RC has two main components: the Data Hub...

Update on Precision Medicine Initiatives

Applying the principles of precision medicine to hematologic diseases is a priority for ASH. Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of...

Special Sessions Offer Inside Look at Peer Review

This year’s meeting will offer two Special-Interest Sessions tailored for all those who have an interest in learning more about both sides of the peer review process. First Editor-in-Chief of Blood Bob Löwenberg, MD, PhD, will lead the discussion “How to Get Published...
Philip Greenberg, MD, to Present the 2019 E. Donnall Thomas Lecture

Philip Greenberg, MD, to Present the 2019 E. Donnall Thomas Lecture

Monday at 9:00 a.m., Philip Greenberg, MD, of Fred Hutchinson Cancer Research Center and University of Washington in Seattle will be awarded the 2019 E. Donnall Thomas Lecture and Prize in recognition of his innovative contributions to the development of T-cell...

Supporting Hematology’s Future: ASH Scholar Award Alums

The ASH Scholar Award is the Society’s longest-standing award program and one of the most highly regarded. For almost three decades, ASH has supported hundreds of fellows and junior faculty in both basic and clinical/translational research by providing partial salary...
Meaningful Outreach Knows No Borders

Meaningful Outreach Knows No Borders

Now entering its third cycle, the ASH Global Research Award was created especially for trainees and early- career investigators based in countries outside of the United States and Canada. It is intended to support these hematologists during the critical period between...
The Cure Sickle Cell Initiative: Rewriting an Old Story

The Cure Sickle Cell Initiative: Rewriting an Old Story

The Cure Sickle Cell Initiative (CureSCi; ) was created by the National Heart, Lung, and Blood Institute to accelerate the development of treatments aimed at a genetic- based cure for sickle cell disease (SCD), and ASH has partnered with the Initiative in an effort to...

ASH Clinical Practice Guidelines Update

ASH has long recognized the need for comprehensive guidelines and in the past three years has broken ground on developing and/or updating guidelines on several disease types, including venous thromboembolism (VTE), immune thrombocytopenia (ITP), acute myeloid leukemia...

Update on ASH Immunotherapies Initiatives

The field of immunotherapy has generated novel immune-based strategies and improved the utility of existing treatment options for various hematologic diseases. As such, ASH has had an enduring interest in improving immunotherapies for all hematologic diseases. This is...

ASH Research Collaborative Data Hub

The Data Hub, a component of the recently launched ASH Research Collaborative (ASH RC), is a technology platform that facilitates the exchange of information by aggregating research-grade data on hematologic diseases in one place and making it available for inquiry....